ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

imeglimin

Also written as “Imeglimin” and “Imeglimin Hydrochloride Film Coated Tablet”.

Its studies are mostly in Diabetes Mellitus, Type 2, led by 2 companies.

Drug pageImeglimin: every studyAll 9 studies of it, academic ones too, with its approvals, label and forms.
Furthest: phase 2, since Sep 19, 20137 company-led studies, 0 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Poxel60 open or runningphase 2since Sep 19, 2013Sep 19, 2013none ahead
Humanis Saglık Anonim Sirketiits history only10 open or runningphase 1since Jul 1, 2026Jul 1, 2026none ahead

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of Poxel only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Sep 19, 2013First study: phase 2 study in Diabetes Mellitus, Type 2First studyNCT01951235 · 315 enrolled · Latvia
  2. Feb 2, 2015Phase 1 study in Diabetes Mellitus, Type 2NCT02373150 · 48 enrolled · United Kingdom
  3. Oct 4, 2016Phase 1 study in Qt Interval, Variation inNCT02924337 · 55 enrolled · United Kingdom
  4. Jun 8, 2018Phase 1 study in HealthyNCT03618316 · 16 enrolled · United Kingdom
  5. Aug 23, 2018Phase 1 study in BioequivalenceNCT03646331 · 16 enrolled · United Kingdom
  6. Jan 10, 2019Phase 1 study in Hepatic ImpairmentNCT03802786 · 14 enrolled · Germany

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 6 Poxel leads, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT03802786Hepatic Impairment · Germany1CompletedJul 3, 201914
NCT03646331Bioequivalence · United Kingdom1CompletedSep 27, 201816
NCT03618316Healthy · United Kingdom1CompletedJul 21, 201816
NCT02924337Qt Interval, Variation in · United Kingdom1CompletedDec 201655
NCT02373150Diabetes Mellitus, Type 2 · United Kingdom1CompletedOct 201548
NCT01951235Diabetes Mellitus, Type 2 · Latvia2CompletedJul 2014315

How it is read

Names in the registry

  • “Imeglimin”, 6 entries
  • “Imeglimin Hydrochloride Film Coated Tablet”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.